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3/14 plants' activity, Reinhard (1999) suggested that synergistic participation of other chemical compounds in the healing process must be taken into account. These include phenolic constituents which consist of flavonoids, phenolic acids (http://www.scialert.net/asci/result.php? searchin=Keywords&cat=&ascicat=ALL&Submit=Search&keyword=phenolic+acids) and tannins which are known for their high antioxidative activity (Balasundram et al., 2006) .
Many investigations indicated that these compounds are of significant value in preventing the onset and/or progression of many human diseases if free radicals or other reactive species caused or significantly contributed to the progression of the disease. Evidence supported the view that increased free radical formation is usually a consequence of tissue damage by a disease or toxin. Thus, phenolic compounds (http://www.scialert.net/asci/result.php? searchin=Keywords&cat=&ascicat=ALL&Submit=Search&keyword=phenolic+compounds)
influence the disease by diminishing damages in cellular structures (Gutteridge and Halliwell, 2010) . Consequently, phenolic compounds (http://www.scialert.net/asci/result.php? searchin=Keywords&cat=&ascicat=ALL&Submit=Search&keyword=phenolic+compounds)
show di erent biological activities such as antibacterial, anticarcinogenic, antiinflammatory, anti-viral, anti-allergic, estrogenic and immune-stimulating agents (Pilarski et al., 2006) . This prompted us to search for antioxidant agents from Malaysian Uncaria species.
Diabetes is characterized by chronic hyperglycemia with disturbance of carbohydrate, fat and protein metabolisms, secondary to an absolute or relative lack of the hormone insulin.
It has a ected a considerable population and is expected to be a major disorder in the future (Alberti and Zimmert, 1998). The two major forms of diabetes are type I (insulindependent) and type II (noninsulin-dependent). Elevated blood sugar (glucose) levels characterize both types. In type I, specifically there is insu icient insulin. Type II diabetes is the most common form of diabetes and is usually characterized by an abnormal rise in blood sugar right a er a meal, called post-prandial hyperglycemia.
α-Glucosidase Inhibitors (AGIs) are among the available glucose-lowering medications taken to decrease post-prandial hyperglycemia. AGIs treat diabetes by decreasing post-prandial hyperglycemia by retarding the absorption of glucose through the inhibition of carbohydrate-hydrolysing enzymes α-glucosidase and α-amylase in the digestive tract (Krentz and Bailey, 2005) . The α-glucosidase enzyme is located in the brush border of the small intestine and is required for the breakdown of carbohydrate to absorbable monosaccharides. The AGIs delay but do not prevent the absorption of ingested carbohydrates thus reducing the postprandial glucose and insulin (Stuart and Gulve, 2004; Andrade-Cetto et al., 2007; Bhandari et al., 2008) . The therapy with synthetic oral hypoglycemic agents can produce serious side e ects and may not be suitable for use during pregnancy (Langer, 2007 found to be e ective, produce minimal or no side e ects in clinical experience and are of relatively low costs as compared to oral synthetic hypoglycemic agents (Gupta et al., 2005) .
This and the traditional use of Asian Uncaria species for diabetes have surged our interest in the search for anti hyperglycemic agents, and in particular, α-glucosidase inhibitors, from the genus.
We have previously reported on the biological activities of Malaysian plants (Ahmad et al., 2005) . In view of the medicinal and therapeutic properties of U. tomentosa and other Uncaria species, this study is now aimed at the evaluation of the antioxidant and antidiabetic potential of five Malaysian Uncaria and to find any correlation between these activities and to a certain extent, relate them to their phytochemical content. Phytochemical screening: Alkaloids were detected by Mayer's reagent (Harborne, 1998) while the presence of flavonoids, saponins and tannins was detected according to Mojab et al. (2003) .
MATERIALS AND METHODS

Plant
Antioxidant assay:
The FTC and TBA assays were carried out as previously described (Tagashira and Ohtake, 1998 62.5, 31.3, 15.6, 7.8 and 3 .9 μg mL ). A er vortexing, the mixture was incubated for 30 min at room temperature. Absorbance at 517 nm was measured. The di erence in absorbance between test sample and control expressed as % inhibition was taken as the activity.
Total phenolic content (TPC):
Total phenolic content of plant extracts was estimated by the Folin-Ciocalteau assay (Waterman and Mole, 1994) .
In-vitro α-Glucosidase inhibitory assay:
The assay was performed according to Khan et al. (2002) with slight modifications. Inhibitory activities of plant extracts against α-glucosidase were studied spectrophotometrically at pH 6.8 and 37°C using 7 mM. p-nitrophenyl-α-D- plant samples (Table 2) to a certain extent, supports Pilarski's findings of high tannin content in the alcoholic extract of U. tomentosa which could contribute significantly to the antioxidant activity observed.
In the evaluation of antioxidant activity (http://www.scialert.net/asci/result.php? searchin=Keywords&cat=&ascicat=ALL&Submit=Search&keyword=antioxidant+activity), the ferric thiocyanate (FTC) method measures the amount of peroxide produced during the initial stages of oxidation which are the primary products of oxidation. tomentosa and U. guianensis.
In-vitro α-glucosidase inhibitory activity:
The e ective treatment of diabetes is increasingly dependent on active constituents of medicinal plants capable of controlling hyperglycemia as well as its secondary complications (Maurya et al., 2008) . The evaluation of antidiabetic potential via α-glucosidase inhibition is expected to lead to the discovery of new, e ective and safe therapeutic agents for the treatment of diabetes. All five Uncaria species tested showed higher percentage of α-glucosidase inhibition compared to the potent α-glucosidase inhibitor 1-deoxynojirimycin hydrochloride. Figure 2 shows the α-glucosidase inhibitory activities of the methanolic extract cordata (leaves), U. lucida (leaves), U. callophylla (stems) and U. longiflora v.p (stems) all exhibited strong inhibitory activities indicated by high percentage of inhibition of more than 95% against the enzyme. However, the leaf extracts of U. acida, U. longiflora v.p. and U.
callophylla showed only moderate inhibition of 49-55%. Interestingly, for U. callophylla and U. longiflora v.p., both stem extracts showed stronger inhibition than the leaves indicating that α-glucosidase inhibitors may be more abundant in the stems than in the leaves.
As shown in diarrhea, arthritis, rheumatism and cancers (Pilarski et al., 2010) . Interestingly, Sandoval et al. (2002) earlier reported that the anti-inflammatory and antioxidant activities of cat's claw (U. tomentosa and U. guianensis) are independent of their oxindole alkaloid content. This was based on a significantly higher content of oxindole alkaloids in the former. The higher potency of the latter consequently suggested that the activities observed are independent of their alkaloid content. Interestingly, in our in-vitro study, the alkaloid-rich and flavonoid-rich U. longiflora v.p.
showed the strongest antioxidant and antidiabetic activity indicating that a synergistic e ect of the phytochemicals may still account for the observed activities and the therapeutic properties of the active plants. On the other hand, the presence of the alkaloids, as argued earlier, may not a ect the antioxidant and antidiabetic activities of the five Uncaria species tested. The evaluation of the activities of isolated alkaloids from the plant should be able to confirm this.
CONCLUSION
In conclusion, we have found that five Malaysian Uncaria species including U. lucida, U.
acida, U. cordata, U. callophylla and U. longiflora var. pteropoda showed strong in vitro (stems) are found to be strong radical scavengers and similarly exhibited strong α-glucosidase inhibitory activities. These activities may be attributed to synergistic e ects of various phytochemicals in both plants. It is anticipated that they can be potentially used in the prevention and control of type II diabetes. In vivo antidiabetic studies of the plants would be our next priority. We are also currently investigating the antioxidant and α-glucosidase inhibitory activities of pentacyclic oxindole alkaloids isolated from U.longiflora v.p. in order to ascertain whether they play a significant role in the antioxidant and antidiabetic potential of the plants.
